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Abstract: 
Due to liver amounts of blood supply through the hepatic artery and portal vein, digestion and detoxification it is prone to 
various diseases including benign and malignant. 
Objective: To examine the characteristics of various liver lesions by using triple phase CT as diagnostic modality, to distinguish 
from benign malignant hepatic lesions and to calculate the effectiveness by associating triple-phase CT findings with 
histopathological, clinical or postoperative findings. 
Study Design:  A cross-sectional study. 
Place and duration: In the Radiology department of Chaudhry Pervaiz Elahi Institute of Cardiology (CPEIC), Multan for one 
year duration from October 2017 to October 2018. 
Methods: A total of 100 patients were included in this cross-sectional study in the Department of Radiology. A triple-phase 
CECT was performed in all patients and their accuracy, sensitivity and specificity were calculated. 
Results: Triple phase CT is an excellent diagnostic method for the characterization and better evaluation of hepatic masses with 
91.3% sensitivity, 97.8% specificity, 91.3% PPV and 97.3% PPV. 8% (p value <0.001, kappa value 0.847). Malignant hepatic 
lesions were 93%, 93.3%, 92.5%, PPV and NPV, 94.9% and 90.2%, respectively, by triple-phase CT, respectively. 
Conclusion: High-precision triple-phase CT useful for reliable diagnosis of liver damage. It has an indispensable role in the 
characterization, evaluation and differentiation of benign and malignant liver lesions that help to guide the appropriate 
treatment plan with adequate surgical classification. It is also useful to reach a diagnosis of primary malignancy in multiple 
hepatic metastases of unknown primary origin. 
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Due to liver amounts of blood supply through the 
hepatic artery and portal vein, digestion and 
detoxification it is prone to various diseases including 
benign and malignant. Most primary and metastatic 
liver tumors take their blood from the hepatic artery, 
thus reversing the normal rate of the hepatic artery 
produced by the portal vein (70%); The main source 
of blood supply. These differences in the blood flow 
pattern form the basis of the triple phase examination 
of the liver [1-2]. This technique has helped to clarify 
the imaging properties of primary and metastatic liver 
tumors. Triple-phase CT is particularly important to 
distinguish benign malignant lesions from benign 
tumors such as hemangioma to avoid unnecessary 
invasive procedures [3-4]. Better detection and 
characterization may be indicative of which liver 
tumors can be subject to aggressive surgical 
techniques and palliative treatment [5]. It explained a 
few work roles, and many were in the western 
populace [6]. This study aims to emphasize the 
characteristics of triple-phase CTs of common liver 
lesions, the role of different stages in the 
characterization of these lesions, and emphasize the 
diagnosis, staging and treatment of patients with 
pathology. The liver can be made more effectively. 
 
MATERIALS AND METHODS: 
This is a prospective study based on the hospital of 
100 cases held in the Radiology department of 
Chaudhry Pervaiz Elahi Institute of Cardiology 
(CPEIC), Multan for one year duration from October 
2017 to October 2018. The study population included 
all patients with suspicious liver mass in clinical, 
laboratory or ultrasound findings. All age groups 
were included in the study. Exclusion criteria were 
patients with renal failure, or patients with a history 
of contrast, allergic reactions, pregnant and 
claustrophobic patients, and focal hepatic lesions 
with infectious etiology such as hydatid cysts and 
hepatic abscess. 
 
CT scans were performed on CT / e Wipro GE 
machine. The study was approved by the ethics and 
scientific committee of the institute and all subjects 




The arterial phase was taken 35-40 seconds after 
contrast injection or 15-20 seconds after bolus 
monitoring. The lesions given by the hepatic artery 
were maximized at this stage. The hepatic or late 
phase of the portal was obtained 70-80 seconds after 
contrast injection or 50-60 seconds after bolus 
follow-up. At this stage, the hepatic veins improved 
with the maximum healing of the hepatic 
parenchyma. Hypovascular lesions were better 
evaluated at this stage. 2-10 minutes after contrast 
injection. Delayed or equilibrium phase was 
obtained. These tumors became visible at this stage, 
which lost their contrast more slowly than normal 
liver parenchyma or was rapidly eliminated. The 
contrast agent used in the study was oral diatrizoate-
meglumine and diatrizoate sodium in 76% and i.v. 30 
minutes before the procedure, low-density oral 
contrast medium, 1000 to 1500 cc water was applied. 
The intravenous contrast dose varied according to the 
patient's weight (1.2-1.5 cc per kg). The injection rate 
was maintained between 2.5 and 5 ml / s, the speed 
adjusted to give a full contrast within about 30 
seconds. (125 ml contrast with 4 ml / sec and 150 ml 
for 5 ml / sec). 
 
statistical methods 
Statistical analysis was performed with a computer 
program (SPSS IBM version 20). Qualitative data 
were expressed as ratio and percentage, and 
quantitative data as mean and standard deviations. 
The difference was analyzed by chi-square test and 
the difference between means was analyzed by 
Student's T test [without analysis]. The significance 
level for the tests was 95%. Therefore, the difference 
was significant if p <0.05. 
 
RESULTS: 
In this study, the population consists of cases with 
ages ranging from 1 to 79, with a maximum number 
of cases between 41 and 50 (30%). 54% of the cases 
were male and 46% were female. 









A total of 36 patients (36%) had the largest group of 
liver metastases. The majority of cases were in the 
41-50 age group (44.4%), followed by the 51-60 age 
group (30.5%). The second largest group (31.1%) 
had hemangioma in 23 cases (23%). The most 
common benign and malignant primary hepatic 





Hemangioma was frequently observed in women 
(69.5%). HCC was 76.9% and secondary liver 
metastasis was 58.3% in males. The overall 
diagnostic accuracy with triple-phase CT in the 
hepatic mass was 96.5%. Triple-phase CT was 
excellent for characterization and better evaluation of 
the hepatic masses with 91.3% sensitivity, 97.8% 
specificity, 91.3% PPV and 97.8% NPV sensitivity (p 
<0.001, kappa value 0.847). 









For better management of patients and an adequate 
surgical classification, benign lesions should be 
distinguished from malignant lesions with precision 
and safety. You can therefore determine which 





The study included 60 malignant and 40 benign 
tumors. Of these, 56 were diagnosed correctly in 
triple-phase CT (94.9%). Malignant lesions can be 
diagnosed with a 93% accuracy, 93.3% and 92.5% 
sensitivity and specificity, and 94.9% and 90.2% 
PPV and NPV with triple phase CTs. (p <0.001 
value, kappa value 0.855). Metastases can be 
distinguished as hypervascular. Triple-phase 
hypovascular or cystic type according to CT features. 
This helps to further identify the primary lesion, 
especially in unknown primary cases. 
 
33 cases of liver metastases were correctly diagnosed 
in triple-phase CT (94.3%). For metastases, the 
triple-phase CT had a diagnostic accuracy of 95%, a 
sensitivity of 91.7%, and a specificity of 96.9% (p 
value <0.001, kappa 0.891). 









The highest number of Adenoma cases was in the 31-
40 age group (71.4%). For hepatic adenoma Triple-
phase CT had a diagnostic accuracy of 99%, a 
sensitivity of 85.7% and a specificity of 100% (p 
value <0.001, kappa 0.799). The maximum incidence 
of cholangiocarcinoma was> 60 years (88.8%). 8 
patients with triple-phase CT were correctly 
diagnosed. There was 98% diagnostic accuracy, 
88.9% sensitivity and 98.9% specificity (p value 




For HCC, triple-phase CT had a diagnostic accuracy 
of 96%, a sensitivity of 84.6% and a specificity of 
97.7% (p value <0.001, kappa 0.823). The vascular 
and anatomical details of the tumor were best 
provided with triple-phase CT, which helped to 
neoadjuvant chemotherapy and surgical or image-
guided surgical planning. 
 
DISCUSSION: 
The study included 16 women and 7 men. Aytekin et 
al. Reported that hemangiomas are more common in 
women. Most of the lesions (90.9%) had only one 
lesion less than 10 cm, only 2 lesions (9%) greater 
than 10 cm and maximum number of cases. The 
Mayo Training and Medical Research Foundation, 
2011, explained that hepatic hemangiomas are small, 
single and do not produce symptoms [7]. 









In simple discovery, 17 cases were hypodense 
(73.9%). In post-contrast examinations, all lesions 
(100%) showed improvement in the arterial phase (18 
lesions showed an early discontinuous peripheral 
nodular improvement, 6 cases showed sudden 
filling), and progressive centrifugal filling in the 
portal venous phase. Central cystic areas were 
observed in 2 cases greater than 10 cm in both. These 
findings were reported by Bartollota et al [8]. In 2 
cases of cirrhosis, regenerative nodules were 
misdiagnosed as hemangioma in the US. However, 
triple-phase CT was correctly diagnosed as 
hemangioma. Although both are benign lesions, they 
do not require surgical intervention. One case of 
hemangioma was diagnosed as false adenoma. 
However, triple phase revealed pathognomonic 
properties of hemangioma on CT9. Three out of 4 
benign lesions (75%) were correctly diagnosed in the 
US On CT, all lesions were correctly diagnosed. Of 
the 41 malignant lesions, 39 (95.12%) were 
diagnosed correctly in USG and 2 (4.88%) were 
misdiagnosed. Triple-phase CT was able to 
accurately diagnose a malignant lesion (97.56%) and 
one (2.44%) misdiagnosed lesion. All 7 cases were 
female (100%) and 31-40 years old (71.4%). All 
lesions were well defined (100%). In USG, 4 lesions 
were hyperechoic (57.1%) and 3 hypoechoic 
(42.8%). A 36-year-old female with a 4-year history 
of hepatitis B had a well-defined hypoechoic valve 




In simple CT, the lesion was hypodense in the 
increased arterial phase lesion and was in the 
photovoltaic and delayed phase of the isodense. The 
lesion was biopsied and the definitive diagnosis was 
adenoma. Therefore, the capsule can be found in both 
HCC and adenoma and should not be differentiation 
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criteria. According to a study by Ichikawa T et al., 
2000, a thin tumor capsule can be defined in about 
25% of cases [11-12]. 
 
FNH: 
Triple patients were middle-aged (100%) and all 
lesions showed well-defined margins (100%). A 38-
year-old woman with a history of Thyroid Ca, a 
hypoechoic lesion in the liver was diagnosed as 
metastatic accumulation in the USG. In the triple 
phase study, the lesion improved in the arterial phase 
and occurred in the photovoltaic phase in isodense 
and delayed phases. Central scarring was also 
observed in delayed discoveries. A diagnosis of FNH 
was made on CT and then confirmed by 
histopathology. Therefore, the lesion was 
misdiagnosed as USG but the correct diagnosis was 
made on CT [13]. 
 
Infantile hemangioendothelioma: 
A 1-year-old man with abdominal distension. He had 
a large heterogeneous hypo-dense lesion on 
abdominal tomography. In a post-contrast study, a 
triple-phase study showed an early discontinuous 
peripheral improvement in the arterial phase with 
progressive centripetal filling in the delayed phase. 
There was also a narrowing of the caliber of the 
celiac aorta [14]. 
 
Biliary cystadenoma: 
Both cases were middle-aged women aged 31-40 
years. According to the Levy AD Murakata LA 
study, biliary cystadenoma is dominant in middle-
aged women. A 37-year-old female patient with a 
history of Ca ovaries had a well-defined lesion with 
cystic metastasis in the right lobe of the liver. 
 
On CT, the lesion showed delayed phase capsule 
development. The definitive diagnosis was made as 
biliary cystadenoma in histopathology. According to 
Palacios E and Buetow PC, the Midkiff RB study in 
CT appears to be a solitary cystic mass with a well-
defined thick fibrous capsule15. Post-contrast scans 
show capsular and septal development. Similar 
findings were found in this study. 
 
Hepatocellular carcinoma, hepatoblastoma, 
cholangiocarcinoma, metastasis and lymphoma were 
best diagnosed by triple phase CT. 
 
CONCLUSION: 
High-precision triple-phase CT is very useful for the 
safe diagnosis of liver masses, has an indispensable 
role in the treatment of benign and malignant liver 
lesions and has also helped to reach a primary 
malignancy diagnosis in multiple liver metastases of 
unknown primary origin. 
 
It evaluates the liver tumor in three different stages, 
which allow a better understanding of the tumor's 
vascular characteristics, which help the diagnosis in 
the diagnosis and treatment protocol. 
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